Država: Malta
Jezik: angleščina
Source: Medicines Authority
sevoflurane 100 % (w/w)
Piramal Healthcare UK Limited
N01AB08
sevoflurane
inhalation vapour, liquid
Authorised
2012-02-24
1 SEVOFLURANE 100% INHALATION VAPOUR, LIQUID Sevoflurane READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU ARE GIVEN THIS MEDICINE. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or nurse. - If any of the side effects get serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or nurse. IN THIS LEAFLET: 1. What Sevoflurane 100% Inhalation Vapour, liquid is and what it is used for 2. Before you are given Sevoflurane 100% Inhalation Vapour, liquid 3. How Sevoflurane 100% Inhalation Vapour, liquid will be given 4. Possible side effects 5. How to store Sevoflurane 100% Inhalation Vapour, liquid 6. Further information 1. WHAT SEVOFLURANE 100% INHALATION VAPOUR, LIQUID IS AND WHAT IT IS USED FOR The active ingredient in Sevoflurane 100% Inhalation Vapour, liquid is sevoflurane, which is a general anaesthetic used for surgical operations and other procedures. It is an inhaled anaesthetic that is given to you as a vapour for you to breathe in. It causes you to fall into a deep sleep (induction of anaesthesia). It also maintains a deep, painless sleep during which you can undergo surgery (maintenance of anaesthesia). 2. WHAT YOU NEED TO KNOW BEFORE YOU ARE GIVEN SEVOFLURANE 100% INHALATION VAPOUR, LIQUID YOU SHOULD NOT BE GIVEN Sevoflurane 100% Inhalation Vapour, liquid IF ANY OF THE FOLLOWING APPLIES TO YOU, PLEASE TELL YOUR DOCTOR IF: you are hypersensitive (or allergy) to sevoflurane or other similar anaesthetic. you, or anyone in your family, are susceptible to a condition called malignant hyperth Preberite celoten dokument
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Sevoflurane 100% Inhalation Vapour, liquid 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Sevoflurane 100%.The finished product is comprised only of the active ingredient, 3. PHARMACEUTICAL FORM Inhalation vapour, liquid Clear, colourless, volatile liquid 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Induction and maintenance of general anaesthesia in adult and paediatric patients of all ages, including full term neonates (see section 4.2 for age details). 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Sevoflurane should be delivered via a vaporizer specifically calibrated for use with Sevoflurane so that the concentration delivered can be accurately controlled. MAC (minimum alveolar concentration) values for sevoflurane decrease as the patient’s age increases and with the addition of nitrous oxide. Dosage should be individualised and titrated to the desired effect according to the patient’s age and clinical status. MAC values for Adults and Paediatric patients according to age Age of Patient (years) Sevoflurane 100% Inhalation Vapour, liquid in Oxygen Sevoflurane 100% Inhalation Vapour, liquid in 65% N 2 O/35% O 2 * 0 – 1 months 3.3% 2.0%** 1 - < 6 months 3.0% 6 months - < 3 years 2.8% 3 – 12 2.5% 25 2.6% 1.4% 40 2.1% 1.1% 60 1.7% 0.9% 80 1.4% 0.7% * Neonates are full term gestational age. MAC in premature infants has not been determined. ** In 1 – 3 year old paediatric patients, 60% N 2 O/40% O 2 was used. Anaesthesia Induction A short acting barbiturate or other intravenous induction agent may be adminis Preberite celoten dokument